On November 9, 2021, The Tokyo High Court rejected Asia Development Capita?s request for an injunction against Tokyo Kikai Seisakusho Ltd.?s planned use of a poison pill. Asia Development had already sought to block the share issue but had that request for an injunction rejected by a lower court. It then appealed to the Tokyo High Court, which rejected it on November 9, 2021. A victory for Tokyo Kikai holds the potential to make it much easier for other Japanese companies to use poison pills.